Trulieve Cannabis (TCNNF) Total Non-Current Liabilities (2020 - 2026)

Trulieve Cannabis (TCNNF) recorded quarterly Total Non-Current Liabilities of $936.2 million in Q1 2026, down 39.27% quarter-over-quarter from $1.5 billion in Q4 2025, and down 2.58% on a YoY basis from $961.0 million in Q1 2025.

Trulieve Cannabis (TCNNF) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Trulieve Cannabis' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $936.2 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 2.58% year-over-year to $936.2 million; the TTM figure through Mar 2026 stood at $936.2 million (down 2.58% YoY), while the FY2025 annual figure was $1.5 billion, down 4.62% from the prior year.
  • Total Non-Current Liabilities was $936.2 million for Q1 2026 at Trulieve Cannabis, down from $1.5 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.7 billion in Q3 2025 to a low of $777.7 million in Q4 2023.
  • Historically, Total Non-Current Liabilities has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities jumped 277.5% in 2022, then slumped 45.65% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $1.4 billion in 2022, then slumped by 45.65% to $777.7 million in 2023, then surged by 107.83% to $1.6 billion in 2024, then declined by 4.62% to $1.5 billion in 2025, then sank by 39.27% to $936.2 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $936.2 million (Q1 2026), $1.5 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Trulieve Cannabis - - 170.08 Mn 936.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 936.23 Mn
Dec 31, 2025 1.54 Bn
Sep 30, 2025 1.74 Bn
Jun 30, 2025 969.72 Mn
Mar 31, 2025 961.05 Mn
Dec 31, 2024 1.62 Bn
Sep 30, 2024 1.56 Bn
Jun 30, 2024 1.16 Bn
Mar 31, 2024 848.48 Mn
Dec 31, 2023 777.68 Mn
Sep 30, 2023 1.25 Bn
Jun 30, 2023 1.35 Bn
Mar 31, 2023 1.41 Bn
Dec 31, 2022 1.43 Bn
Sep 30, 2022 1.30 Bn
Jun 30, 2022 1.34 Bn
Mar 31, 2022 1.40 Bn
Dec 31, 2021 1.26 Bn
Sep 30, 2021 446.96 Mn
Jun 30, 2021 360.10 Mn